Seeking to cure cancer
Finding a cure for cancer is one of the longest and most intense efforts of sustained innovation and experiment in history. Here you will find links to thousands of patents, patent application, and related literature for innovations that share the common purpose of ending the scourge of cancer.
| No | Document | Title | Date | Score |
|---|---|---|---|---|
| 1 |
CA 2679290 A1
patent application
|
A method for detection of liver cancer, risk of liver cancer, risk of recurrence of liver cancer, malignancy of liver cancer and progression of liver cancer with time by using themethylated cytosine in basp1 gene and/Or srd5a2 gene
The present invention provides a novel method for detection of liver cancer. This method detects high-sensitively, high-specifically, simply and accurately...
|
12-Sep-2008 |
|
| 2 |
EP 2184352 A1
patent application
|
Double-stranded nucleic acid molecule, cancer cell proliferation inhibitor and pharmaceutical agent suitable for prevention or treatment of uterine cancer, breast cancer and bladder cancer
The present invention aims to provide a double-stranded nucleic acid molecule (e.g., siRNA) which can effectively inhibit the proliferation of uterine, breast...
|
12-May-2010 |
|
| 3 |
EP 2404596 A1
patent application
|
Kit for Cancer Treatment and Pharmaceutical Composition for Cancer Treatment
To provide a kit for cancer treatment and a pharmaceutical composition for cancer treatment that can inhibit the growth of tumors and cancers in mammals more...
|
11-Jan-2012 |
|
| 4 |
EP 1427403 A2
patent application
|
Valproic acid for the treatment of breast cancer, colon cancer, head and neck cancer, small cell lung carcinoma and cancer of the blood cells in combination with irradiation | 16-Jun-2004 |
|
| 5 |
CA 2512961 A1
patent application
|
Cancer comprehensive method for identifying cancer protein patterns and determination of cancer treatment strategies
A cancer therapy comprehensive method for characterizing a cancer tumor for medical diagnosis and treatment. The method facilitates determination of a cancer...
|
29-Jul-2004 |
|
| 6 |
CA 2561835 A1
patent application
|
Improvements in cancer treatment and cancer treatment efficacy prediction by blocking and detecting protease inhibitors
Disclosed is a method for improving cancer therapy that relies on induction of apoptosis in malignant cells. It has been found that docking of protease ...
|
13-Oct-2005 |
|
| 7 |
EP 1427403 B1
patent document
|
Valproic acid for the treatment of breast cancer, colon cancer, head and neck cancer, small cell lung carcinoma and cancer of the blood cells in combination with irradiation | 28-Dec-2005 |
|
| 8 |
CA 2687254 A1
patent application
|
Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments
The present invention relates to administration of milk fat or a milk fat analogue, optionally with at least one additional therapeutic factor, preferably...
|
20-Nov-2008 |
|
| 9 |
EP 1427403 B8
patent document
|
Valproic acid for the treatment of breast cancer, colon cancer, head and neck cancer, small cell lung carcinoma and cancer of the blood cells in combination with irradiation | 22-Mar-2006 |
|
| 10 |
EP 2359828 A1
patent application
|
HDAC inhibitors and hormone targeted drugs for the treatment of cancer
The present invention relates to the methods of treating endocrine-regulated cancers, including hormone resistant cancers, for example. More specifically, the...
|
24-Aug-2011 |
|
| 11 |
1942446
PRC translation
|
Pyrazoline derivatives useful for the treatment of cancer
The present invention relates to new substituted pyrazoline compounds, pharmaceutical compositions containing such compounds and the use of these compounds for...
|
04-Apr-2007 |
|
| 12 |
US 2004/0142490 A1
patent application
|
Method of using estrogen-related receptor gamma (ERRgamma) status to determine prognosis and treatment strategy for breast cancer, method of using ERRgamma as a therapeutic target for treating breast cancer, method of using ERRgamma to diagnose breast cancer, and method of using ERRgamma to identify individuals predisposed to breast cancer
The present invention provides that ERRγ is both a breast cancer biomarker and a breast cancer treatment target. A high ERRγ level in breast cancer cells...
|
22-Jul-2004 |
|
| 13 |
EP 2146739 A2
patent application
|
Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments | 27-Jan-2010 |
|
| 14 |
CA 2514552 A1
patent application
|
Adjuvant used in dielectric heating-assisted cancer treatment, and cancer treatment method
An auxiliary agent whereby cauterization range can be enlarged and uneven cauterization can be lessened in a dielectric heating therapy for cancer, for ...
|
12-Aug-2004 |
|
| 15 |
CA 2556478 A1
patent application
|
Pyrazoline derivatives useful for the treatment of cancer
The present invention relates to new substituted pyrazoline compounds, pharmaceutical compositions containing such compounds and the use of these compounds...
|
25-Aug-2005 |
|
| 16 |
CA 2661665 A1
patent application
|
A pharmaceutical composition for treating lung cancer, a method for inhibiting growth or invasion of lung cancer and a method for treating lung cancer
Disclosed herein are a pharmaceutical composition for inhibiting the proliferation or metastasis of lung cancer cells, comprising a substance inhibiting the...
|
28-Feb-2008 |
|
| 17 |
US 7332525 B2
patent document
|
Method of treatment of prostate cancer and composition for treatment thereof
A method and composition for the treatment of prostate cancer comprises an effective amount of a nonsteroidal antiandrogen and an effective amount of a...
|
19-Feb-2008 |
|
| 18 |
US 5911995
patent document
|
EGF-genistein conjugates for the treatment of cancer
A conjugate formed of epidermal growth factor covalently linked to a tyrosine kinase inhibitor, such as genistein, and a method for killing cancer cells, in...
|
15-Jun-1999 |
|
| 19 |
US 2006/0062756 A1
patent application
|
Method of cancer screening; method of cancer treatment; method of diabetes treatment; method of multiple sclerosis treatment; method of interstitial cystitis treatment; method of acquired immune deficiency syndrome treatment; and method of herpes treatment
A method of cancer screening comprising the steps of administering the Blood CA 27,29 test; administering a mammogram; administering an needle biopsy;...
|
23-Mar-2006 |
|
| 20 |
US 7354713 B2
patent document
|
Method of using estrogen-related receptor gamma (ERRγ) status to determine prognosis and treatment strategy for breast cancer, method of using ERRγ as a therapeutic target for treating breast cancer, method of using ERRγ to diagnose breast cancer, and method of using ERRγ to identify individuals predisposed to breast cancer
The present invention provides that ERRγ is both a breast cancer biomarker and a breast cancer treatment target. A high ERRγ level in breast cancer cells...
|
08-Apr-2008 |
|
| 21 |
EP 1459070 A2
patent application
|
Methods for diagnosis and treatment of epithelial-derived cancers, such as colorectal cancers and kidney cancers | 22-Sep-2004 |
|
| 22 |
EP 1742650 A1
patent application
|
Improvements in cancer treatment and cancer treatment efficacy prediction by blocking and detecting protease inhibitors | 17-Jan-2007 |
|
| 23 |
US 8034359 B2
patent document
|
Tissue targeted antigenic activation of the immune response to cancers
The invention provides in part methods of treating cancers of a specific organ or tissue by administering a composition that is antigenically specific for one...
|
11-Oct-2011 |
|
| 24 |
EP 2371864 A1
patent application
|
Monoclonal antibodies for treatment of cancer
The present invention provides antibodies useful as therapeutics for treating and/or preventing diseases associated with cells expressing GT468, including...
|
05-Oct-2011 |
|
| 25 |
EP 1455781 A1
patent application
|
Use of anastrozole for the treatment of post-menopausal women having early breast cancer | 15-Sep-2004 |
|
| 26 |
EP 1380644 A1
patent application
|
The use of specified TCF target genes to identify drugs for the treatment of cancer, in particular colorectal cancer, in which TCF/beta-catenin/WNT signalling plays a central role
The present invention relates to the use of
inhibitors of the expressed proteins of TCF target genes
whose expression is regulated by TCF/β-catenin complexes...
|
14-Jan-2004 |
|
| 27 |
US 5821254
patent document
|
Uses of 9-cis-retinoic acids and derivatives thereof alone or in combination with antineoplastic agents in the prevention or treatment of cancer
This invention relates to methods and compositions for preventing or treating cancer. Specifically this invention relates to the use of 9-cis-retinoic acid or...
|
13-Oct-1998 |
|
| 28 |
US 6342483 B1
patent document
|
Method for detection and treatment of breast cancer
The present invention provides a method of detecting and diagnosing pre-invasive breast cancer by identifying differentially expressed genes in early,...
|
29-Jan-2002 |
|
| 29 |
EP 1384788 A1
patent application
|
Examination method for judging treatment for cancer, reagent for the examination and method of screening remedy relating to cancer
A method is provided to study gene function based on variations of the
amino acids and the base sequences at specific positions on HLA genes which
have...
|
28-Jan-2004 |
|
| 30 |
EP 1676132 A1
patent application
|
System and method for the treatment of cancer, including cancers of the central nervous system | 05-Jul-2006 |
|
| 31 |
CA 2604288 A1
patent application
|
Use of a galectin-1-targeted rnai-based approach for the treatment of cancer
The present invention relates to an RNAi molecule suitable for reducing the expression of galectin-1 containing any of the sequences of SEQ ID NOs: 1-33, and...
|
19-Oct-2006 |
|
| 32 |
US 7183251 B1
patent document
|
hCG therapy for the treatment of breast cancer
This invention relates to the field of cancer therapy. More particularly, the invention relates to the treatment of mammary tumor, clinically manifest mammary...
|
27-Feb-2007 |
|
| 33 |
EP 1800691 A3
patent application
|
Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
The present invention relates to compositions and methods for the prevention and/or treatment of bone loss associated with cancer. More particularly, the...
|
31-Oct-2007 |
|
| 34 |
US 2010/0173405 A1
patent application
|
Double-Stranded Nucleic Acid Molecule Cancer Cell Proliferation Inhibitor and Pharmaceutical Agent Suitable for Prevention or Treatment of Uterine Cancer, Breast Cancer, and Bladder Cancer
A double-stranded nucleic acid molecule for suppressing the expression of at least one of COX7RP and Efp genes which includes (a) a sense strand which includes...
|
08-Jul-2010 |
|
| 35 |
CA 2454664 C
patent document
|
Cancer treatment with go6976 and its related compounds
A chemotheraputic cancer treatment in which Gö6976 or a compound chemically similar to Gö6976 is administered to a mammal for the treatment of the cancer. The...
|
27-Oct-2009 |
|
| 36 |
US 6638727 B1
patent document
|
Methods for identifying treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer
The invention is to methods for identifying asymptomatic patients who have a likelihood of benefiting from administration of an estrogen activity modulator for...
|
28-Oct-2003 |
|
| 37 |
US 7541141 B2
patent document
|
Method of using estrogen-related receptor alpha (ERRα) status to determine prognosis, treatment strategy and predisposition to breast cancer, and method of using ERRα as a therapeutic target for the treatment of breast cancer
The present invention provides that ERRα is a breast cancer biomarker of clinical course and treatment sensitivity and, itself, a target for breast cancer...
|
02-Jun-2009 |
|
| 38 |
CA 2349406 A1
patent application
|
Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
The present invention relates to compositions and methods for the prevention and/or treatment of bone loss associated with cancer. More particularly, the ...
|
15-Mar-2001 |
|
| 39 |
EP 2272982 A1
patent application
|
Method for treatment of prostate cancer and diagnosing of patients benefiting from the same
The invention relates to a method for treating ERG-positive prostate cancer patients with an agent counteracting one or more ERG-associated genes and/or...
|
12-Jan-2011 |
|
| 40 |
CA 2349406 C
patent document
|
Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
The present invention relates to compositions and methods for the prevention and/or treatment of bone loss associated with cancer. More particularly, the ...
|
11-Jan-2011 |
|
| 41 |
US 5759776
patent document
|
Targets for breast cancer diagnosis and treatment
cDNA sequences derived from four novel genes associated with breast cancer are provided. In over about 60% of the cancer cell lines tested, RNA hybridizing with...
|
02-Jun-1998 |
|
| 42 |
CA 2297727 A1
patent application
|
Detection and treatment of breast, gynecological and prostate cancer
The present invention provides novel DNA sequences and polypeptides, which are associated with breast, gynecological, and prostate carcinomas. The present ...
|
25-Feb-1999 |
|
| 43 |
CA 2344155 A1
patent application
|
Methods for selecting prostate cancer treatments and treating prostate cancer
A method for selection treatment for or treating a patient afflicted with prostate cancer by determining whether the number of copies of HER-2/neu gene in...
|
22-Mar-2001 |
|
| 44 |
EP 1455781 B1
patent document
|
Use of anastrozole for the treatment of post-menopausal women having early breast cancer | 27-Aug-2008 |
|
| 45 |
CA 2499628 A1
patent application
|
Combination treatment of cancer using a cancer vaccine and a chemotherapeutic drug
The invention is a method of treating a patient suffering from cancer. In the method, an agent for stimulating an immune response against the cancer and a ...
|
01-Apr-2004 |
|
| 46 |
EP 0505220 A1
patent application
|
New compounds for use in the treatment of cancer
Compounds of the formula:
wherein R3 is hydrogen, alkyl or hydroxymethyl, and R1 and R²
are hydrogen, alkyl or an electron withdrawing organic group...
|
23-Sep-1992 |
|
| 47 |
US 8110550 B2
patent document
|
HDAC inhibitors and hormone targeted drugs for the treatment of cancer
The present invention relates to the methods of treating endocrine-regulated cancers, including hormone resistant cancers, for example. More specifically, the...
|
07-Feb-2012 |
|
| 48 |
JP 2006-167046 A
patent application
|
Cancer treatment state evaluation method and device and cancer treatment method and apparatus
PROBLEM TO BE SOLVED: To provide a highly reliable cancer treatment apparatus or the like capable of evaluating treatment states in the process of treatment by...
|
29-Jun-2006 |
|
| 49 |
EP 1800691 A2
patent application
|
Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
The present invention relates to compositions and methods for the prevention and/or treatment of bone loss associated with cancer. More particularly, the...
|
27-Jun-2007 |
|
| 50 |
EP 1232177 B1
patent document
|
Methods and compositions for detection and treatment of breast cancer, based on breast cancer-associated polypeptides | 21-Feb-2007 |
|
| 51 |
CA 2446518 A1
patent application
|
Method of screening agents for the treatment and prevention of cancer and cachexia and the new use of specific agents for the treatment and prevention of cancer and cachexia
A method for screening agents to determine possible use as treatment and prevention drugs is provided. More specifically, cells, living organisms, mammals, or ...
|
28-Apr-2004 |
|
| 52 |
EP 2306187 A1
patent application
|
Cancer eradication program
A method of treating breast cancer that is at least partially ER¿+? is disclosed. The method comprises administering at a tumor site in a mammalian subject a...
|
06-Apr-2011 |
|
| 53 |
EP 2105740 A1
patent application
|
Biomarkers for monitoring or predicting the treatment of cancer
The invention is directed to biomarkers for determining the c-myc activity in a subject, and the use thereof for predicting and monitoring therapeutic...
|
30-Sep-2009 |
|
| 54 |
CA 2491947 A1
patent application
|
The use of specified tcf target genes to identify drugs for the treatment of cancer, in particular colorectal cancer, in which tcf/.Beta.-catenin/Wnt signalling plays a central role
The present invention relates to the use of inhibitors of the expressed proteins of TCF target genes whose expression is regulated by TCF/.beta.- catenin...
|
15-Jan-2004 |
|
| 55 |
US 6409664 B1
patent document
|
Nomograms to aid in the treatment of prostatic cancer
This invention relates to methods and apparatus for predicting probability of cancer recurrence following radical prostatectomy using predetermined clinical and...
|
25-Jun-2002 |
|
| 56 |
EP 2302385 A1
patent application
|
Methods for selecting treatment regimens and predicting outcomes in cancer patients
The present invention relates to methods for determining a treatment regimen beyond removal of tumor tissue for node negative or node positive breast cancer...
|
30-Mar-2011 |
|
| 57 |
EP 2060259 A1
patent application
|
Medical compositions for intravesical treatment of bladder cancer
An anti-cancer formulation comprising: 5-(1-azaridinyl)-3-(hydroxymethyl)-2-[(E)-3-hydroxyprop-1-enyl]-1-methyl-1H-indole-4,7-dione (EO9) and a buffered...
|
20-May-2009 |
|
| 58 |
CA 2732594 A1
patent application
|
Monoclonal antibodies for treatment of cancer
The present invention provides antibodies useful as therapeutics for treating and/or preventing diseases associated with cells expressing GT468, including...
|
25-Mar-2010 |
|
| 59 |
CA 2554818 A1
patent application
|
Diagnosis and treatment of cancers with microrna located in or near cancer-associated chromosomal features
MicroRNA genes are highly associated with chromosomal features involved in the etiology of different cancers. The perturbations in the genomic structure or ...
|
25-Aug-2005 |
|
| 60 |
EP 2360476 A1
patent application
|
Methods for selecting treatment regimens and predicting outcomes in cancer patients
The present invention relates to methods for determining a treatment regimen beyond removal of tumor tissue for node negative or node positive breast cancer...
|
24-Aug-2011 |
|
| 61 |
US 5773579
patent document
|
Lung cancer marker
The present invention discloses an isolated and purified nucleic acid sequence and corresponding amino acid sequence to a novel protein specific for human lung...
|
30-Jun-1998 |
|
| 62 |
CA 2454664 A1
patent application
|
Cancer treatment with go6976 and its related compounds
A chemotheraputic cancer treatment in which Gö6976 or a compound chemically similar to Gö6976 is administered to a mammal for the treatment of the cance r. The...
|
06-Feb-2003 |
|
| 63 |
EP 2272984 A1
patent application
|
Use of ID4 for diagnosis and treatment of cancer
Methods for diagnosis and treatment of cancer using ID4 are disclosed. Specifically, epigenetic inactivation of ID4 in colorectal carcinomas and breast...
|
12-Jan-2011 |
|
| 64 |
US 6858388 B2
patent document
|
Methods and compositions for detecting cancers associated with methylation of hMLH1 promoter DNA
Methods are provided for detection of cancers associated with methylation of hMLH1 promoter DNA in a subject. The method comprise assaying for the presence of...
|
22-Feb-2005 |
|
| 65 |
US 5788964
patent document
|
Method for sensitization of cancer cells for killer cell mediated lysis
The invention relates to a method of sensitizing cancer cells for a killer cell mediated lysis which involves administering to a patient an effective amount of...
|
04-Aug-1998 |
|
| 66 |
EP 2165715 A1
patent application
|
Therapeutic agent for cancer, and method for treatment of cancer
[PROBLEMS] To provide a technique which enables an effective antibody therapy for cancer which targets for FGFR1 without the need of using any effective...
|
24-Mar-2010 |
|
| 67 |
US 7220730 B2
patent document
|
Cancer specific radiolabeled conjugates regulated by the cell cycle for the treatment and diagnosis of cancer
Radiolabeled conjugates are disclosed which have a component that is effective to target tumor cells, which cells selectively take up and degrade the conjugate,...
|
22-May-2007 |
|
| 68 |
EP 2386854 A1
patent application
|
Diagnostic markers of breast cancer treatment and progression and methods of use thereof
To maximize both the life expectancy and quality of life of patients with operable breast cancer, it is important to predict adjuvant treatment outcome and...
|
16-Nov-2011 |
|
| 69 |
EP 1713511 B1
patent document
|
Therapeutic agent for treatment of cancer comprising human apolipoprotein (A) kringles lk68 or lk8 genes as effective ingredient, and method for treating cancer using the same | 09-Nov-2011 |
|
| 70 |
EP 2103628 A1
patent application
|
Anti-claudin-3 monoclonal antibody, and treatment and diagnosis of cancer using the same
Monoclonal antibodies that bind specifically to Claudin 3 expressed on cell surface are provided. The antibodies of the present invention are useful for...
|
23-Sep-2009 |
|
| 71 |
JP 2008-245635 A
patent application
|
Method for detection of liver cancer, risk of liver cancer, risk of reccurence of liver cancer, malignancy of liver cancer and progression of liver cancer with time by using methylated cytosine in basp1 gene and/Or srd5a2 gene
PROBLEM TO BE SOLVED: To provide a new method for detection of liver cancer. SOLUTION: This method detects high-sensitively, high-specifically, simply and...
|
16-Oct-2008 |
|
| 72 |
CA 2593541 A1
patent application
|
Identification of phospholipase a2 as target in cancer treatment, with special emphasis on colorectal cancer and its mechanism of action
A peptide of phospholipase A2 had been detected in human plasma and synthesised. The peptide was injected into mice and gene expression profiling on many...
|
20-Jul-2006 |
|
| 73 |
CA 2672581 A1
patent application
|
Anti-claudin 3 monoclonal antibody and treatment and diagnosis of cancer using the same
Disclosed are: a monoclonal antibody capable of binding specifically to Claudin-3 expressed on the surface of a cell, which is useful for the diagnosis of...
|
19-Jun-2008 |
|
| 74 |
EP 2333119 A1
patent application
|
Predicting breast cancer treatment outcome
Methods and compositions are provided for the identification of expression signatures in ER+ breast cancer cases, where the signatures correlate with...
|
15-Jun-2011 |
|
| 75 |
101675171 A
PRC translation
|
A method for detection of liver cancer, risk of liver cancer, risk of recurrence of liver cancer, malignancy of liver cancer and progression of liver cancer with time by using the methylated cytosine
The present invention provides a novel method for detection of liver cancer. This method detects high-sensitively, high-specifically, simply and accurately...
|
17-Mar-2010 |
|
| 76 |
US 6852316 B2
patent document
|
Cancer treatment
The present invention relates to the use of angiotensin in a method for the treatment or prevention of cancer. The method comprises administering to a patient...
|
08-Feb-2005 |
|
| 77 |
JP 2010-280568 A
patent application
|
Diagnostic agent and therapeutic agent for lung cancer, prostate cancer, breast cancer, ovarian cancer and melanoma
PROBLEM TO BE SOLVED: To provide a diagnostic method and a therapeutic method for technologies of early cancer diagnoses, while early cancer treatments are...
|
16-Dec-2010 |
|
| 78 |
US 7767200 B2
patent document
|
Cancer treatment using viruses, fluoropyrimidines and camptothecins
Mammalian subjects having a neoplasm are treated with a virus, a fluoropyrimidine, for example 5-fluorouracil, and a camptothecin compound. The virus is...
|
03-Aug-2010 |
|
| 79 |
US 6096301
patent document
|
Combined interferon/antiestrogen therapy for treatment of breast cancer
Proliferation of breast cancer is treated by a combined type I interferon/non-steroidal antiestrogen therapy. Preferably antiestrogen treatment is sequential to...
|
01-Aug-2000 |
|
| 80 |
CA 2399999 A1
patent application
|
Use of breast cancer associated membrane proteins (Bcmp) for treatment, prophylaxis and diagnosis of breast cancer
The present invention provides methods and compositions for screening, diagnosis and prognosis of breast cancer, for monitoring the effectiveness of breast...
|
30-Aug-2001 |
|
| 81 |
US 7662553 B2
patent document
|
Polymorphisms in the ERCC1 gene for predicting treatment outcome
The invention provides compositions and methods for determining the increased risks for recurrence of certain cancers and the likelihood of successful treatment...
|
16-Feb-2010 |
|
| 82 |
US 6670392 B2
patent document
|
Compositions and methods for the prevention and treatment of human prostate cancer
The invention provides a composition and method for the prevention or treatment of mammalian prostate carcinoma using Vitamin E or Vitamin E derivatives or...
|
30-Dec-2003 |
|
| 83 |
US 7648826 B1
patent document
|
Detecting CYP24 expression level as a marker for predisposition to cancer
This invention pertains to the discovery that an amplification of the CYP24 gene or an increase in CYP24 activity is a marker for the presence of, progression...
|
19-Jan-2010 |
|
| 84 |
US 6703380 B2
patent document
|
Prevention of cancer
The present invention relates to a method for the prevention of cancer or the initiation and/or progression of cancer in a human comprising administration to...
|
09-Mar-2004 |
|
| 85 |
EP 1545592 A1
patent application
|
Combination treatment of cancer using a cancer vaccine and a chemotherapeutic drug | 29-Jun-2005 |
|
| 86 |
EP 1140136 A2
patent application
|
Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer | 10-Oct-2001 |
|
| 87 |
EP 1951683 A1
patent application
|
Pyrimidine derivatives for the treatment of cancer | 06-Aug-2008 |
|
| 88 |
CA 2705417 A1
patent application
|
Treatment of uterine cancer and ovarian cancer with a parp inhibitor alone or in combination with anti-tumor agents | 22-May-2009 |
|
| 89 |
CA 2640013 A1
patent application
|
Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers
A four arm-polyethylene glycol-7-ethyl-l0-hydroxycamptothecin conjugate, such as Formula (I), is disclosed. Methods of making the conjugates and methods of ...
|
16-Aug-2007 |
|
| 90 |
US 2004/0137539 A1
patent application
|
Cancer comprehensive method for identifying cancer protein patterns and determination of cancer treatment strategies
A cancer therapy comprehensive method for characterizing a cancer tumor for medical diagnosis and treatment. The method facilitates determination of a cancer...
|
15-Jul-2004 |
|
| 91 |
EP 1945627 A1
patent application
|
Pyrimidine derivatives for the treatment of cancer | 23-Jul-2008 |
|
| 92 |
EP 1232177 A2
patent application
|
Methods and compositions for detection and treatment of breast cancer, based on breast cancer-associated polypeptides | 21-Aug-2002 |
|
| 93 |
EP 1843784 A2
patent application
|
Identification of phospholipase a2 as target in cancer treatment, with special emphasis on colorectal cancer and its mechanism of action | 17-Oct-2007 |
|
| 94 |
EP 1117842 A1
patent application
|
Methods for selecting prostate cancer treatments and treating prostate cancer | 25-Jul-2001 |
|
| 95 |
EP 1079840 B1
patent document
|
Synergistic composition of inulin and an anti-cancer drug for use in the treatment of cancer | 02-Oct-2002 |
|
| 96 |
EP 1713938 A2
patent application
|
Diagnosis and treatment of cancers with microrna located in or near cancer-associated chromosomal features | 25-Oct-2006 |
|
| 97 |
EP 1257285 A2
patent application
|
Use of breast cancer associated membrane proteins (Bcmp) for treatment, prophylaxis and diagnosis of breast cancer | 20-Nov-2002 |
|
| 98 |
EP 1012159 A1
patent application
|
Detection and treatment of breast, gynecological and prostate cancer | 28-Jun-2000 |
|
| 99 |
EP 1140136 B1
patent document
|
Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer | 16-May-2007 |
|
| 100 |
US 8044033 B2
patent document
|
Fluorocytidine derivatives and COX-2 inhibitors for the treatment of cancer
The present invention provides, in certain embodiments, methods for the treatment of colorectal cancer comprising administering a COX-2 inhibitor and...
|
25-Oct-2011 |
|
Copyright © 2009-2012 IP.com. All Rights Reserved.
